KERATOSIS BLENNORRHAGICA
1949; American Medical Association; Volume: 59; Issue: 3 Linguagem: Inglês
10.1001/archderm.1949.01520280036004
ISSN2376-3760
Autores Tópico(s)Skin and Cellular Biology Research
ResumoIN THE half-century which has elapsed since the original description of keratosis blennorrhagica by Vidal 1 in 1893, it has become generally agreed that this disease represents a distinct clinical entity. In 1942 Keim 2 analyzed the disease from an etiologic standpoint and described the fundamental histologic changes. Since that time numerous investigators have anvanced methods of treatment; these have in the main been directed against the general infection, local treatment proving to be of little value. Among the therapeutic measures reported favorably are intravenous injections of 1 per cent solution of merbromin N. F., (mercurochrome R ), by Willmott 3 in 1926, and the use of autogenous vaccines, by Scholtz, 4 about one year later. Downing 5 reported rapid recovery in a patient following double vesiculectomy and prostatotomy. Sherman, Blumenthal and Heidenreich 6 stressed the importance of treating the primary focus and stated the opinion that local treatment of the
Referência(s)